Trial Site Detail

 

Drug:
Cobimetinib + MPDL3280A
Trial:
A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Site name unknown, Singapore 188770

     
Singapore , 188770
Singapore

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown, Singapore 188770 Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.